Prescription drug · NDA
Cystadrops (Cysteamine hydrochloride) NDC 55292-410
Cysteamine hydrochloride 3.5 mg/mL · Solution · Ophthalmic · RECORDATI RARE DISEASES, INC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 55292-410-05 | 5529204100555292041005 | 1 BOTTLE, GLASS in 1 BOX (55292-410-05) / 5 mL in 1 BOTTLE, GLASSMarketed from Aug 19, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Cystadrops
- Generic name (nonproprietary)
- cysteamine hydrochloride
- Active ingredients
- Cysteamine hydrochloride — 3.5 mg/mL
- Dosage form
- Solution
- Route
- Ophthalmic
- Labeler
- RECORDATI RARE DISEASES, INC.NDC labeler code 55292
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 211302
- Marketing start
- Listing expires
- Other FDA classes
- Cystine Disulfide Reduction (Mechanism)
- Identifiers
- Product ID 55292-410_34dba967-28b4-4fc8-876d-2e30d32a0f95SPL ID 34dba967-28b4-4fc8-876d-2e30d32a0f95SPL set ID 5d2bcce3-9b89-4141-aeb7-db00449047f5UNII IF1B771SVB
- Pharmacologic class
- Cystine Depleting Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N455292041005followed by a unit qualifier and the quantityPackage 55292-0410-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
CYSTADROPS is a cystine-depleting agent indicated for the treatment of corneal cystine crystal deposits in adults and children with cystinosis. CYSTADROPS is a cystine-depleting agent indicated for the treatment of corneal cystine crystal deposits in adults and children with cystinosis. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 55292-410
- What is NDC 55292-410?
- 55292-410 is the product NDC for Cystadrops (cysteamine hydrochloride), Cysteamine hydrochloride 3.5 mg/mL solution, listed with the FDA by RECORDATI RARE DISEASES, INC.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Cystadrops (Cysteamine hydrochloride).
- What is the active ingredient?
- Cysteamine hydrochloride.
- Who is the labeler?
- RECORDATI RARE DISEASES, INC., NDC labeler code 55292. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Cystadrops?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.